Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2026-08-14 17:11:16 ET · period of report 2026-08-12 · accession 0001539215-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 17:11 | 2026-08-12 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | +2,500 | 19.8K | +14% | $0 |
| D | 2026-08-14 17:11 | 2026-08-12 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | F - Tax | $46.57 | -1,158 | 18.6K | -6% | -$53.9K |
| D | 2026-08-14 17:11 | 2026-08-12 | SUPN | Bhatt Padmanabh P. | CSO, SVP of IP | M - OptEx | $0.00 | -2,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-12 | M | A | 2,500 | $0.00 | 19,795 | D | — | — | (F1) Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-08-12 | F | D | 1,158 | $46.57 | 18,637 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 3 | Derivative | Performance Share Unit | 2026-08-12 | M | D | 2,500 | $0.00 | 0 | D | $0.00 · — to — | 2,500 Common Stock | (F3) On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025. (F3) On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025. |